Newsletter Archive
Archives: 2005 | 2006 | 2007 | 2008 | 2009

05/11/09
Healthcare Japan #3

- Technology to detect avian influenza viruses in about 10 minutes, developed jointly by Sysmex Co. and Osaka Prefectural Institute of Public Health
- Teijin Pharma and Takeda Pharmaceutical to market the gout/hyperuricemia drug “febuxostat” in the U.S.
- And more



03/16/09
Healthcare Japan #2

- Yakult Honsha Signs an Exclusive License Agreement on Cancer Drug ThermoDox(R) in Japan
- Takeda Pharmaceutical Obtains Approval on the Efficacy of a Combination Therapy Using Type II Diabetes Drug “Actos®” and Biguanide Agent
- And more



01/28/09
Healthcare Japan #1

- The Revised Pharmaceutical Affairs Law to Take Effect, Effectively Changing the Way Drugs Are Marketed
- Teva Pharmaceutical and Kowa Enter into a Strategic Partnership on Generic Drugs
- And more